Best TWAS P=3.27e-09 · Best GWAS P=7.7e-08 conditioned to 0.626
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | METTL10 | 0.20 | 0.26 | lasso | 9 | 0.26 | 4.5e-31 | 5.2 | 5.2 | 2.0e-07 | 0.97 | 0.02 | 0.98 | FALSE |
2 | GTEx | Breast Mammary Tissue | METTL10 | 0.13 | 0.08 | enet | 19 | 0.13 | 4.8e-07 | 4.3 | 5.4 | 8.6e-08 | 0.77 | 0.04 | 0.96 | FALSE |
3 | GTEx | Lung | METTL10 | 0.11 | 0.06 | enet | 6 | 0.05 | 1.7e-04 | 5.2 | 5.3 | 1.4e-07 | 0.95 | 0.02 | 0.98 | FALSE |
4 | GTEx | Skin Sun Exposed Lower leg | METTL10 | 0.05 | 0.04 | enet | 8 | 0.04 | 2.1e-04 | 4.2 | 5.4 | 7.6e-08 | 0.82 | 0.03 | 0.94 | FALSE |
5 | GTEx | Testis | METTL10 | 0.26 | 0.14 | lasso | 9 | 0.08 | 2.3e-04 | 5.3 | 5.3 | 9.6e-08 | 0.94 | 0.02 | 0.98 | FALSE |
6 | GTEx | Thyroid | METTL10 | 0.19 | 0.09 | enet | 33 | 0.10 | 3.0e-08 | 5.2 | 5.1 | 3.1e-07 | 0.83 | 0.02 | 0.98 | FALSE |
7 | METSIM | Adipose | METTL10 | 0.12 | 0.15 | enet | 27 | 0.15 | 1.1e-21 | 5.2 | 5.2 | 1.7e-07 | 0.93 | 0.02 | 0.98 | FALSE |
8 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | METTL10 | 0.09 | 0.08 | blup | 43 | 0.11 | 1.2e-09 | 5.3 | 5.9 | 3.3e-09 | 0.94 | 0.01 | 0.99 | TRUE |
9 | The Cancer Genome Atlas | Breast Invasive Carcinoma | METTL10 | 0.06 | 0.13 | lasso | 7 | 0.13 | 1.1e-25 | 5.4 | 5.3 | 1.0e-07 | 0.98 | 0.01 | 0.99 | FALSE |
10 | The Cancer Genome Atlas | Colon Adenocarcinoma | METTL10 | 0.09 | 0.14 | lasso | 9 | 0.12 | 3.1e-07 | 5.4 | 5.5 | 4.8e-08 | 1.00 | 0.01 | 0.99 | FALSE |
11 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | METTL10 | 0.10 | 0.14 | blup | 43 | 0.14 | 7.4e-16 | 5.3 | 5.5 | 3.7e-08 | 0.97 | 0.01 | 0.99 | FALSE |
12 | The Cancer Genome Atlas | Brain Lower Grade Glioma | METTL10 | 0.13 | 0.16 | blup | 43 | 0.18 | 1.8e-20 | 5.3 | 5.4 | 6.3e-08 | 0.89 | 0.01 | 0.99 | FALSE |
13 | The Cancer Genome Atlas | Lung Adenocarcinoma | METTL10 | 0.11 | 0.19 | lasso | 6 | 0.19 | 7.3e-22 | 5.2 | 5.3 | 1.1e-07 | 0.98 | 0.01 | 0.99 | FALSE |
14 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | METTL10 | 0.05 | 0.06 | lasso | 4 | 0.06 | 9.2e-05 | 4.8 | 5.3 | 1.4e-07 | 0.91 | 0.02 | 0.96 | FALSE |
15 | The Cancer Genome Atlas | Rectum Adenocarcinoma | METTL10 | 0.25 | 0.11 | lasso | 4 | 0.23 | 3.8e-06 | 5.4 | 5.8 | 5.1e-09 | 0.86 | 0.02 | 0.88 | FALSE |
16 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | METTL10 | 0.39 | 0.21 | lasso | 5 | 0.21 | 2.9e-06 | 4.8 | 5.2 | 2.3e-07 | 0.80 | 0.03 | 0.95 | FALSE |
17 | The Cancer Genome Atlas | Thyroid Carcinoma | METTL10 | 0.25 | 0.35 | lasso | 5 | 0.36 | 5.9e-36 | 5.2 | 5.3 | 1.3e-07 | 0.96 | 0.02 | 0.98 | FALSE |
18 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | METTL10 | 0.13 | 0.08 | blup | 43 | 0.12 | 2.4e-04 | 5.2 | 5.9 | 4.2e-09 | 0.95 | 0.01 | 0.93 | FALSE |